Eyam Vaccines and Immunotherapeutics Announces Clinical Trials Agreement for Next-Generation COVID-19 Vaccine
VANCOUVER, BC / ACCESSWIRE / September 8, 2021 / Eyam Vaccine and Immunotherapeutics (EYAM), a next-generation vaccine biotechnology company, announced today...